Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
6
×
national blog main
national top stories
san francisco blog main
6
×
life sciences
biotech
boston blog main
boston top stories
national
new york blog main
san francisco top stories
detroit blog main
detroit top stories
fda
raleigh-durham blog main
texas blog main
texas top stories
wisconsin blog main
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
companion diagnostic
foundation medicine
indiana blog main
indiana top stories
keytruda
new york top stories
precision medicine
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin top stories
arboretum ventures
arena pharmaceuticals
aurora health care
baird capital
What
medicine
6
×
cancer
drug
fda
genetic
new
patients
risks
acquire
agreed
allison
ann
approved
arbor
based
big
billion
broad
cancers
cas
cells
closed
company
confidence
countless
crispr
deeper
defect
didn’t
dna
drive
edited
editing
eisai
fears
fight
fingerprint
flag
flags
foundation
Language
unset
Current search:
cancer
×
medicine
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round